Genentech's goal is to deliver innovative medicines to patients with serious or life-threatening medical conditions. Since its founding in 1976, the company's research organization has focused its drug discovery efforts on therapies that would fill unmet needs. Today, Genentech manufactures and commercializes multiple biotherapeutics for critical medical conditions in the areas of oncology, immunology, and disorders of tissue growth and repair — giving Genentech one of the leading product portfolios in the biotech industry.

For 20 years, Genentech has been committed to making sure price is not a barrier to access for patients. For those who do not have insurance or who need assistance with co-payments or reimbursement, Genentech supports several programs for eligible patients treated for approved indications in the United States. Read about Genentech's various patient access programs and donations.